Thank you for subscribing!
Finfeed Archived Nov 18, 2019
With over 40 years’ experience in the healthcare diagnostic imaging industry, Imagion Biosystems (ASX:IBX) Board member Mike Harsh is one of the world’s most qualified people to speak about the evolution of diagnostics.
Finfeed Archived Oct 24, 2019
Redbubble closed up 22% to finish at $177.5c on $5.4 million stock traded. The reason: they released strategic and financial updates for the first quarter (1Q) ended 30 September 2019.
Finfeed Archived Oct 23, 2019
The TechKnow Invest Roadshow provides retail and institutional investors, as well as brokers, an opportunity to learn more about a range of tech and biotech companies.
Finfeed Archived Oct 03, 2019
Immuron’s (ASX:IMC) second clinical-stage asset, IMM-529, targets Clostridium difficile Infections (CDI), and is presently in a clinical trial in CDI patients.
Get expert stock analysis direct in your inbox
Finfeed Archived Oct 02, 2019
Actinogen Medical (ASX:ACW) released extremely promising results from the XanaHES (Xanamem in Healthy Elderly Subjects) trial.
Actinogen closed up 466% to finish at 5.1c on $15.8 million stock traded. The company announced results from the XanaHES (Xanamem in Healthy Elderly Subjects) trial. The results demonstrate a significant improvement in cognition in trial participants dosed with Xanamem 20mg daily for 12 weeks, compared to placebo.
Finfeed Archived Sep 24, 2019
Osteopore yesterday closed up 260% (yes that's right) to finish at 72.5c on $4.6 million stock traded. The reason: they listed. Osteopore is one of the hottest, if not the hottest, IPOs in the last few years.
Finfeed Archived Sep 23, 2019
Provider of world-leading genetic risk assessment test products Genetic Technologies Limited (ASX:GTG), has signed a 3-year Collaboration Agreement with TGen.
Finfeed Archived Sep 19, 2019
Some of today’s stocks would love to be as hot as Jimi Hendrix in his prime. That’s certainly what they are aiming for.
Join Our Mailing List
